2025年1月7日 · TMZ MR is indicated for the symptomatic treatment of stable angina pectoris in patients inadequately controlled or intolerant to first line therapies. Patients should be …

Trimetazidine is usually prescribed as a long-term treatment of angina pectoris, and in some countries (including France) for tinnitus and dizziness. It is taken twice a day.

2024年8月4日 · Trimetazidine (TMZ) is a medication used to treat heart-related conditions like angina. It helps metabolize fatty acids, which helps your body use oxygen. The drug allows...

2025年3月19日 · Trimetazidine inhibits fatty acid metabolism and stimulates the metabolism of glucose. It helps the body use oxygen, which relieves chest pain caused by blocked blood …

The main trimetazidine formulations available on the market are the 20 mg immediate-release (IR) tablets administered 3 times a day and the 35 mg modified-release (MR) tablets, developed …

2015年5月12日 · Trimetazidine is a piperazine derivative indicated as an adjunct therapy in symptomatic treatment of stable angina pectoris. Trimetazidine is not FDA approved. …

A new formulation of TMZ modified-release (MR) 80 mg was developed, which is to be taken once daily (od), instead of twice daily (bid) for the currently available TMZ MR 35 mg, with the aim of …

Trimetazidine is a cytoprotective drug that normalizes metabolic disturbances in low-flow ischemia via several—not yet fully understood—mechanisms of action. The best known trimetazidine …

2018年5月19日 · A new formulation of TMZ modified-release (MR) 80 mg was developed, which is to be taken once daily (od), instead of twice daily (bid) for the currently available TMZ MR 35 …

2015年3月10日 · TMZ treatment inhibited I/R-induced JAK2/STAT3 signaling pathway activation in ovarian tissues. TMZ administration also improved the increase in the mRNA expressions of …